Vietnam Drug Administration Urges End To Hospital Drug Shortage
This article was originally published in PharmAsia News
Vietnam's Drug Administration is urging the nation's hospitals to overcome a shortage in drug supplies by changing the way they purchase them. The head of the agency advised the institutions to buy cheaper versions of drugs and invite drug suppliers to bid directly with the hospitals. Some drug distributors who saw the price of raw materials rise after they had signed contracts with the hospitals have refused to supply the drugs at the original price. Others are supplying only small quantities of orders until they can charge more. Many drug companies signed contracts earlier this year, guaranteeing the same prices for six to 12 months. (Click here for more
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.